Fundraising Fox

Altis Biosystems

Delaware corporation · 7 known investors

altisbiosystems.com ↗

Altis Biosystems builds RepliGut®, human intestinal tissue models grown from human intestinal stem cells that provide human-relevant preclinical data for drug absorption, metabolism, toxicity, and disease modeling. It serves pharmaceutical and life-science researchers as an alternative to animal studies and Caco-2 cell lines, offering ready-to-use kits and custom studies.

BiotechDeep TechHealthtechMedical Devicesin /altisbiosystems@AltisBioInc

Founders & leadership

CS
Christopher SimsExecutive Officer
JS
Jimmy SmedleyExecutive Officer
SF
Samuel FranklinDirector
JM
Joseph McMahonDirector
MB
Michael BironExecutive Officer, Director
SP
Swetha PeddibhotlaSenior Scientist
CP
Christopher PerkinsDirector
MD
Michael DialDirector
BS
Benjamin ScruggsExecutive Officer, Director
SM
Susan MahonyDirector
KC
Kevin CauseyDirector

Investors · 7

Atlanta Technology AngelsAtlanta · $200K – $2M
Central Texas Angel NetworkAustin
Checkmate Capital Group LLCPasadena
IDEA NCDurham · $250K – $2M
Johnson Venture PartnersAtlanta · $50K – $500K
VentureSouthGreenville
Hatteras Venture PartnersreportedResearch Triangle · $500K – $4M

Reported raises · per SEC filings

Form D private placements
▶$2.1MraisedApr 2025 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Christopher PerkinsDirector
  • Michael DialDirector
  • Christopher SimsExecutive Officer
  • Benjamin ScruggsExecutive Officer, Director
  • Jimmy SmedleyExecutive Officer
  • Susan MahonyDirector
  • Kevin CauseyDirector
Offering amount
$2.3M
Amount sold
$2.1M
First sale
Mar 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.4MraisedAug 2022 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Benjamin ScruggsDirector
  • Joseph McMahonDirector
  • Samuel FranklinDirector
  • Christopher SimsExecutive Officer, Director
  • Susan MahonyDirector
  • Michael BironExecutive Officer, Director
Offering amount
$5M
Amount sold
$1.4M
First sale
Jul 2022
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.1MraisedJul 2020 · 42 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Samuel FranklinDirector
  • Joseph McMahonDirector
  • Michael BironExecutive Officer, Director
  • Christopher SimsExecutive Officer, Director
  • Susan MahonyDirector
Offering amount
$3.1M
Amount sold
$3.1M
First sale
Dec 2019
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.